Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein

Paul M. Ridker; Francisco A.H. Fonseca; Jacques Genest; Antonio M. Gotto; John J.P. Kastelein; Nardev S. Khurmi; Wolfgang Koenig; Peter Libby; Alberto J. Lorenzatti; Borge G. Nordestgaard; James Shepherd; James T. Willerson; Robert J. Glynn

The American Journal of Cardiology (2007) - Comments
pubmed: 18036365 doi: 10.1016/j.amjcard.2007.09.072 issn: 0002-9149

Paul M. Ridker, Francisco A.H. Fonseca, Jacques Genest, Antonio M. Gotto, John J.P. Kastelein, Nardev S. Khurmi, Wolfgang Koenig, Peter Libby, Alberto J. Lorenzatti, Borge G. Nordestgaard, James Shepherd, James T. Willerson, Robert J. Glynn,